nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Photoabsorption—Methoxsalen—psoriasis	0.454	0.5	CiPCiCtD
Verteporfin—Photosensitizing Activity—Methoxsalen—psoriasis	0.454	0.5	CiPCiCtD
Verteporfin—Eye disorder—Dexamethasone—psoriasis	5.43e-05	0.000591	CcSEcCtD
Verteporfin—Eye disorder—Betamethasone—psoriasis	5.43e-05	0.000591	CcSEcCtD
Verteporfin—Back pain—Triamcinolone—psoriasis	5.39e-05	0.000587	CcSEcCtD
Verteporfin—Malaise—Hydrocortisone—psoriasis	5.34e-05	0.000581	CcSEcCtD
Verteporfin—Nervous system disorder—Cyclosporine—psoriasis	5.33e-05	0.00058	CcSEcCtD
Verteporfin—Loss of consciousness—Prednisolone—psoriasis	5.33e-05	0.00058	CcSEcCtD
Verteporfin—Vertigo—Hydrocortisone—psoriasis	5.32e-05	0.000579	CcSEcCtD
Verteporfin—Body temperature increased—Mycophenolic acid—psoriasis	5.32e-05	0.000578	CcSEcCtD
Verteporfin—Syncope—Hydrocortisone—psoriasis	5.31e-05	0.000578	CcSEcCtD
Verteporfin—Dizziness—Hydroxyurea—psoriasis	5.31e-05	0.000577	CcSEcCtD
Verteporfin—Oedema—Mycophenolate mofetil—psoriasis	5.31e-05	0.000577	CcSEcCtD
Verteporfin—Skin disorder—Cyclosporine—psoriasis	5.28e-05	0.000575	CcSEcCtD
Verteporfin—Angiopathy—Betamethasone—psoriasis	5.27e-05	0.000574	CcSEcCtD
Verteporfin—Angiopathy—Dexamethasone—psoriasis	5.27e-05	0.000574	CcSEcCtD
Verteporfin—Hyperhidrosis—Cyclosporine—psoriasis	5.26e-05	0.000572	CcSEcCtD
Verteporfin—Hypertension—Prednisolone—psoriasis	5.24e-05	0.00057	CcSEcCtD
Verteporfin—Shock—Mycophenolate mofetil—psoriasis	5.22e-05	0.000568	CcSEcCtD
Verteporfin—Loss of consciousness—Hydrocortisone—psoriasis	5.21e-05	0.000566	CcSEcCtD
Verteporfin—Nervous system disorder—Mycophenolate mofetil—psoriasis	5.2e-05	0.000566	CcSEcCtD
Verteporfin—Ill-defined disorder—Triamcinolone—psoriasis	5.17e-05	0.000563	CcSEcCtD
Verteporfin—Skin disorder—Mycophenolate mofetil—psoriasis	5.15e-05	0.000561	CcSEcCtD
Verteporfin—Hyperhidrosis—Mycophenolate mofetil—psoriasis	5.13e-05	0.000558	CcSEcCtD
Verteporfin—Hypertension—Hydrocortisone—psoriasis	5.11e-05	0.000556	CcSEcCtD
Verteporfin—Discomfort—Prednisolone—psoriasis	5.1e-05	0.000555	CcSEcCtD
Verteporfin—Haemoglobin—Prednisone—psoriasis	5.09e-05	0.000553	CcSEcCtD
Verteporfin—Haemorrhage—Prednisone—psoriasis	5.06e-05	0.000551	CcSEcCtD
Verteporfin—Rash—Hydroxyurea—psoriasis	5.06e-05	0.000551	CcSEcCtD
Verteporfin—Dermatitis—Hydroxyurea—psoriasis	5.06e-05	0.00055	CcSEcCtD
Verteporfin—Malaise—Triamcinolone—psoriasis	5.03e-05	0.000547	CcSEcCtD
Verteporfin—Headache—Hydroxyurea—psoriasis	5.03e-05	0.000547	CcSEcCtD
Verteporfin—Vertigo—Triamcinolone—psoriasis	5.01e-05	0.000545	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	5.01e-05	0.000545	CcSEcCtD
Verteporfin—Syncope—Triamcinolone—psoriasis	5e-05	0.000544	CcSEcCtD
Verteporfin—Discomfort—Hydrocortisone—psoriasis	4.98e-05	0.000542	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Cyclosporine—psoriasis	4.96e-05	0.000539	CcSEcCtD
Verteporfin—Oedema—Prednisolone—psoriasis	4.95e-05	0.000538	CcSEcCtD
Verteporfin—Loss of consciousness—Triamcinolone—psoriasis	4.9e-05	0.000533	CcSEcCtD
Verteporfin—Shock—Prednisolone—psoriasis	4.87e-05	0.00053	CcSEcCtD
Verteporfin—Cough—Triamcinolone—psoriasis	4.87e-05	0.000529	CcSEcCtD
Verteporfin—Dyspnoea—Cyclosporine—psoriasis	4.85e-05	0.000527	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	4.83e-05	0.000526	CcSEcCtD
Verteporfin—Oedema—Hydrocortisone—psoriasis	4.83e-05	0.000526	CcSEcCtD
Verteporfin—Photosensitivity reaction—Methotrexate—psoriasis	4.82e-05	0.000525	CcSEcCtD
Verteporfin—Asthenia—Mycophenolic acid—psoriasis	4.82e-05	0.000525	CcSEcCtD
Verteporfin—Hypertension—Triamcinolone—psoriasis	4.82e-05	0.000524	CcSEcCtD
Verteporfin—Hyperhidrosis—Prednisolone—psoriasis	4.78e-05	0.00052	CcSEcCtD
Verteporfin—Nausea—Hydroxyurea—psoriasis	4.77e-05	0.000519	CcSEcCtD
Verteporfin—Pruritus—Mycophenolic acid—psoriasis	4.76e-05	0.000517	CcSEcCtD
Verteporfin—Shock—Hydrocortisone—psoriasis	4.76e-05	0.000517	CcSEcCtD
Verteporfin—Nervous system disorder—Hydrocortisone—psoriasis	4.74e-05	0.000516	CcSEcCtD
Verteporfin—Pneumonia—Methotrexate—psoriasis	4.74e-05	0.000516	CcSEcCtD
Verteporfin—Eye disorder—Prednisone—psoriasis	4.73e-05	0.000515	CcSEcCtD
Verteporfin—Dyspnoea—Mycophenolate mofetil—psoriasis	4.73e-05	0.000515	CcSEcCtD
Verteporfin—Flushing—Prednisone—psoriasis	4.7e-05	0.000511	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Cyclosporine—psoriasis	4.7e-05	0.000511	CcSEcCtD
Verteporfin—Skin disorder—Hydrocortisone—psoriasis	4.7e-05	0.000511	CcSEcCtD
Verteporfin—Ill-defined disorder—Dexamethasone—psoriasis	4.7e-05	0.000511	CcSEcCtD
Verteporfin—Ill-defined disorder—Betamethasone—psoriasis	4.7e-05	0.000511	CcSEcCtD
Verteporfin—Discomfort—Triamcinolone—psoriasis	4.69e-05	0.00051	CcSEcCtD
Verteporfin—Hyperhidrosis—Hydrocortisone—psoriasis	4.67e-05	0.000508	CcSEcCtD
Verteporfin—Pain—Cyclosporine—psoriasis	4.65e-05	0.000506	CcSEcCtD
Verteporfin—Constipation—Cyclosporine—psoriasis	4.65e-05	0.000506	CcSEcCtD
Verteporfin—Angiopathy—Prednisone—psoriasis	4.59e-05	0.0005	CcSEcCtD
Verteporfin—Conjunctivitis—Methotrexate—psoriasis	4.58e-05	0.000498	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	4.58e-05	0.000498	CcSEcCtD
Verteporfin—Immune system disorder—Prednisone—psoriasis	4.57e-05	0.000497	CcSEcCtD
Verteporfin—Malaise—Dexamethasone—psoriasis	4.56e-05	0.000496	CcSEcCtD
Verteporfin—Malaise—Betamethasone—psoriasis	4.56e-05	0.000496	CcSEcCtD
Verteporfin—Oedema—Triamcinolone—psoriasis	4.55e-05	0.000495	CcSEcCtD
Verteporfin—Vertigo—Betamethasone—psoriasis	4.55e-05	0.000495	CcSEcCtD
Verteporfin—Vertigo—Dexamethasone—psoriasis	4.55e-05	0.000495	CcSEcCtD
Verteporfin—Syncope—Betamethasone—psoriasis	4.54e-05	0.000494	CcSEcCtD
Verteporfin—Syncope—Dexamethasone—psoriasis	4.54e-05	0.000494	CcSEcCtD
Verteporfin—Constipation—Mycophenolate mofetil—psoriasis	4.54e-05	0.000494	CcSEcCtD
Verteporfin—Pain—Mycophenolate mofetil—psoriasis	4.54e-05	0.000494	CcSEcCtD
Verteporfin—Sweating—Methotrexate—psoriasis	4.52e-05	0.000491	CcSEcCtD
Verteporfin—Feeling abnormal—Cyclosporine—psoriasis	4.48e-05	0.000488	CcSEcCtD
Verteporfin—Shock—Triamcinolone—psoriasis	4.48e-05	0.000487	CcSEcCtD
Verteporfin—Loss of consciousness—Dexamethasone—psoriasis	4.45e-05	0.000484	CcSEcCtD
Verteporfin—Loss of consciousness—Betamethasone—psoriasis	4.45e-05	0.000484	CcSEcCtD
Verteporfin—Dizziness—Mycophenolic acid—psoriasis	4.45e-05	0.000484	CcSEcCtD
Verteporfin—Malnutrition—Prednisone—psoriasis	4.41e-05	0.000479	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	4.4e-05	0.000479	CcSEcCtD
Verteporfin—Hyperhidrosis—Triamcinolone—psoriasis	4.4e-05	0.000479	CcSEcCtD
Verteporfin—Feeling abnormal—Mycophenolate mofetil—psoriasis	4.37e-05	0.000476	CcSEcCtD
Verteporfin—Hypertension—Dexamethasone—psoriasis	4.37e-05	0.000475	CcSEcCtD
Verteporfin—Hypertension—Betamethasone—psoriasis	4.37e-05	0.000475	CcSEcCtD
Verteporfin—Urticaria—Cyclosporine—psoriasis	4.32e-05	0.00047	CcSEcCtD
Verteporfin—Body temperature increased—Cyclosporine—psoriasis	4.3e-05	0.000468	CcSEcCtD
Verteporfin—Discomfort—Betamethasone—psoriasis	4.26e-05	0.000463	CcSEcCtD
Verteporfin—Discomfort—Dexamethasone—psoriasis	4.26e-05	0.000463	CcSEcCtD
Verteporfin—Haemoglobin—Methotrexate—psoriasis	4.25e-05	0.000463	CcSEcCtD
Verteporfin—Rash—Mycophenolic acid—psoriasis	4.24e-05	0.000461	CcSEcCtD
Verteporfin—Dermatitis—Mycophenolic acid—psoriasis	4.24e-05	0.000461	CcSEcCtD
Verteporfin—Pain—Prednisolone—psoriasis	4.23e-05	0.00046	CcSEcCtD
Verteporfin—Haemorrhage—Methotrexate—psoriasis	4.23e-05	0.00046	CcSEcCtD
Verteporfin—Urticaria—Mycophenolate mofetil—psoriasis	4.22e-05	0.000459	CcSEcCtD
Verteporfin—Headache—Mycophenolic acid—psoriasis	4.21e-05	0.000458	CcSEcCtD
Verteporfin—Pharyngitis—Methotrexate—psoriasis	4.2e-05	0.000457	CcSEcCtD
Verteporfin—Body temperature increased—Mycophenolate mofetil—psoriasis	4.19e-05	0.000456	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Hydrocortisone—psoriasis	4.17e-05	0.000454	CcSEcCtD
Verteporfin—Vision blurred—Prednisone—psoriasis	4.15e-05	0.000452	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Triamcinolone—psoriasis	4.15e-05	0.000451	CcSEcCtD
Verteporfin—Pain—Hydrocortisone—psoriasis	4.13e-05	0.00045	CcSEcCtD
Verteporfin—Oedema—Betamethasone—psoriasis	4.13e-05	0.000449	CcSEcCtD
Verteporfin—Oedema—Dexamethasone—psoriasis	4.13e-05	0.000449	CcSEcCtD
Verteporfin—Ill-defined disorder—Prednisone—psoriasis	4.09e-05	0.000445	CcSEcCtD
Verteporfin—Feeling abnormal—Prednisolone—psoriasis	4.08e-05	0.000444	CcSEcCtD
Verteporfin—Visual impairment—Methotrexate—psoriasis	4.08e-05	0.000444	CcSEcCtD
Verteporfin—Anaemia—Prednisone—psoriasis	4.07e-05	0.000443	CcSEcCtD
Verteporfin—Shock—Dexamethasone—psoriasis	4.06e-05	0.000442	CcSEcCtD
Verteporfin—Shock—Betamethasone—psoriasis	4.06e-05	0.000442	CcSEcCtD
Verteporfin—Dyspnoea—Triamcinolone—psoriasis	4.06e-05	0.000441	CcSEcCtD
Verteporfin—Nervous system disorder—Dexamethasone—psoriasis	4.05e-05	0.000441	CcSEcCtD
Verteporfin—Nervous system disorder—Betamethasone—psoriasis	4.05e-05	0.000441	CcSEcCtD
Verteporfin—Hypersensitivity—Cyclosporine—psoriasis	4.01e-05	0.000436	CcSEcCtD
Verteporfin—Nausea—Mycophenolic acid—psoriasis	3.99e-05	0.000434	CcSEcCtD
Verteporfin—Hyperhidrosis—Dexamethasone—psoriasis	3.99e-05	0.000434	CcSEcCtD
Verteporfin—Hyperhidrosis—Betamethasone—psoriasis	3.99e-05	0.000434	CcSEcCtD
Verteporfin—Feeling abnormal—Hydrocortisone—psoriasis	3.98e-05	0.000433	CcSEcCtD
Verteporfin—Malaise—Prednisone—psoriasis	3.97e-05	0.000432	CcSEcCtD
Verteporfin—Vertigo—Prednisone—psoriasis	3.96e-05	0.000431	CcSEcCtD
Verteporfin—Eye disorder—Methotrexate—psoriasis	3.95e-05	0.00043	CcSEcCtD
Verteporfin—Syncope—Prednisone—psoriasis	3.95e-05	0.00043	CcSEcCtD
Verteporfin—Urticaria—Prednisolone—psoriasis	3.93e-05	0.000428	CcSEcCtD
Verteporfin—Cardiac disorder—Methotrexate—psoriasis	3.93e-05	0.000427	CcSEcCtD
Verteporfin—Hypersensitivity—Mycophenolate mofetil—psoriasis	3.91e-05	0.000425	CcSEcCtD
Verteporfin—Asthenia—Cyclosporine—psoriasis	3.9e-05	0.000424	CcSEcCtD
Verteporfin—Pain—Triamcinolone—psoriasis	3.89e-05	0.000423	CcSEcCtD
Verteporfin—Loss of consciousness—Prednisone—psoriasis	3.87e-05	0.000421	CcSEcCtD
Verteporfin—Pruritus—Cyclosporine—psoriasis	3.85e-05	0.000419	CcSEcCtD
Verteporfin—Urticaria—Hydrocortisone—psoriasis	3.84e-05	0.000418	CcSEcCtD
Verteporfin—Angiopathy—Methotrexate—psoriasis	3.84e-05	0.000418	CcSEcCtD
Verteporfin—Immune system disorder—Methotrexate—psoriasis	3.82e-05	0.000416	CcSEcCtD
Verteporfin—Body temperature increased—Hydrocortisone—psoriasis	3.82e-05	0.000416	CcSEcCtD
Verteporfin—Asthenia—Mycophenolate mofetil—psoriasis	3.81e-05	0.000414	CcSEcCtD
Verteporfin—Hypertension—Prednisone—psoriasis	3.8e-05	0.000414	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Betamethasone—psoriasis	3.76e-05	0.000409	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.76e-05	0.000409	CcSEcCtD
Verteporfin—Pruritus—Mycophenolate mofetil—psoriasis	3.75e-05	0.000408	CcSEcCtD
Verteporfin—Arthralgia—Prednisone—psoriasis	3.75e-05	0.000408	CcSEcCtD
Verteporfin—Feeling abnormal—Triamcinolone—psoriasis	3.75e-05	0.000408	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	3.73e-05	0.000405	CcSEcCtD
Verteporfin—Discomfort—Prednisone—psoriasis	3.71e-05	0.000403	CcSEcCtD
Verteporfin—Malnutrition—Methotrexate—psoriasis	3.68e-05	0.000401	CcSEcCtD
Verteporfin—Hypersensitivity—Prednisolone—psoriasis	3.65e-05	0.000397	CcSEcCtD
Verteporfin—Urticaria—Triamcinolone—psoriasis	3.62e-05	0.000393	CcSEcCtD
Verteporfin—Body temperature increased—Triamcinolone—psoriasis	3.6e-05	0.000391	CcSEcCtD
Verteporfin—Dizziness—Cyclosporine—psoriasis	3.6e-05	0.000391	CcSEcCtD
Verteporfin—Oedema—Prednisone—psoriasis	3.6e-05	0.000391	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Betamethasone—psoriasis	3.57e-05	0.000388	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Dexamethasone—psoriasis	3.57e-05	0.000388	CcSEcCtD
Verteporfin—Back pain—Methotrexate—psoriasis	3.56e-05	0.000388	CcSEcCtD
Verteporfin—Hypersensitivity—Hydrocortisone—psoriasis	3.56e-05	0.000387	CcSEcCtD
Verteporfin—Shock—Prednisone—psoriasis	3.54e-05	0.000385	CcSEcCtD
Verteporfin—Pain—Dexamethasone—psoriasis	3.53e-05	0.000384	CcSEcCtD
Verteporfin—Pain—Betamethasone—psoriasis	3.53e-05	0.000384	CcSEcCtD
Verteporfin—Nervous system disorder—Prednisone—psoriasis	3.53e-05	0.000384	CcSEcCtD
Verteporfin—Dizziness—Mycophenolate mofetil—psoriasis	3.51e-05	0.000382	CcSEcCtD
Verteporfin—Skin disorder—Prednisone—psoriasis	3.49e-05	0.00038	CcSEcCtD
Verteporfin—Hyperhidrosis—Prednisone—psoriasis	3.48e-05	0.000378	CcSEcCtD
Verteporfin—Vision blurred—Methotrexate—psoriasis	3.47e-05	0.000378	CcSEcCtD
Verteporfin—Asthenia—Hydrocortisone—psoriasis	3.47e-05	0.000377	CcSEcCtD
Verteporfin—Rash—Cyclosporine—psoriasis	3.43e-05	0.000373	CcSEcCtD
Verteporfin—Dermatitis—Cyclosporine—psoriasis	3.43e-05	0.000373	CcSEcCtD
Verteporfin—Pruritus—Hydrocortisone—psoriasis	3.42e-05	0.000372	CcSEcCtD
Verteporfin—Ill-defined disorder—Methotrexate—psoriasis	3.42e-05	0.000372	CcSEcCtD
Verteporfin—Headache—Cyclosporine—psoriasis	3.41e-05	0.000371	CcSEcCtD
Verteporfin—Anaemia—Methotrexate—psoriasis	3.4e-05	0.00037	CcSEcCtD
Verteporfin—Feeling abnormal—Betamethasone—psoriasis	3.4e-05	0.00037	CcSEcCtD
Verteporfin—Feeling abnormal—Dexamethasone—psoriasis	3.4e-05	0.00037	CcSEcCtD
Verteporfin—Hypersensitivity—Triamcinolone—psoriasis	3.35e-05	0.000365	CcSEcCtD
Verteporfin—Rash—Mycophenolate mofetil—psoriasis	3.35e-05	0.000364	CcSEcCtD
Verteporfin—Dermatitis—Mycophenolate mofetil—psoriasis	3.34e-05	0.000364	CcSEcCtD
Verteporfin—Headache—Mycophenolate mofetil—psoriasis	3.32e-05	0.000362	CcSEcCtD
Verteporfin—Malaise—Methotrexate—psoriasis	3.32e-05	0.000361	CcSEcCtD
Verteporfin—Vertigo—Methotrexate—psoriasis	3.31e-05	0.00036	CcSEcCtD
Verteporfin—Urticaria—Betamethasone—psoriasis	3.28e-05	0.000357	CcSEcCtD
Verteporfin—Urticaria—Dexamethasone—psoriasis	3.28e-05	0.000357	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Prednisone—psoriasis	3.28e-05	0.000356	CcSEcCtD
Verteporfin—Dizziness—Prednisolone—psoriasis	3.27e-05	0.000356	CcSEcCtD
Verteporfin—Asthenia—Triamcinolone—psoriasis	3.27e-05	0.000355	CcSEcCtD
Verteporfin—Body temperature increased—Betamethasone—psoriasis	3.26e-05	0.000355	CcSEcCtD
Verteporfin—Body temperature increased—Dexamethasone—psoriasis	3.26e-05	0.000355	CcSEcCtD
Verteporfin—Nausea—Cyclosporine—psoriasis	3.23e-05	0.000351	CcSEcCtD
Verteporfin—Pruritus—Triamcinolone—psoriasis	3.22e-05	0.00035	CcSEcCtD
Verteporfin—Cough—Methotrexate—psoriasis	3.21e-05	0.00035	CcSEcCtD
Verteporfin—Dizziness—Hydrocortisone—psoriasis	3.2e-05	0.000348	CcSEcCtD
Verteporfin—Nausea—Mycophenolate mofetil—psoriasis	3.15e-05	0.000343	CcSEcCtD
Verteporfin—Arthralgia—Methotrexate—psoriasis	3.14e-05	0.000341	CcSEcCtD
Verteporfin—Chest pain—Methotrexate—psoriasis	3.14e-05	0.000341	CcSEcCtD
Verteporfin—Rash—Prednisolone—psoriasis	3.12e-05	0.000339	CcSEcCtD
Verteporfin—Dermatitis—Prednisolone—psoriasis	3.12e-05	0.000339	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.11e-05	0.000339	CcSEcCtD
Verteporfin—Headache—Prednisolone—psoriasis	3.1e-05	0.000337	CcSEcCtD
Verteporfin—Discomfort—Methotrexate—psoriasis	3.1e-05	0.000337	CcSEcCtD
Verteporfin—Constipation—Prednisone—psoriasis	3.08e-05	0.000335	CcSEcCtD
Verteporfin—Rash—Hydrocortisone—psoriasis	3.05e-05	0.000332	CcSEcCtD
Verteporfin—Dermatitis—Hydrocortisone—psoriasis	3.05e-05	0.000331	CcSEcCtD
Verteporfin—Headache—Hydrocortisone—psoriasis	3.03e-05	0.000329	CcSEcCtD
Verteporfin—Dizziness—Triamcinolone—psoriasis	3.01e-05	0.000327	CcSEcCtD
Verteporfin—Feeling abnormal—Prednisone—psoriasis	2.96e-05	0.000322	CcSEcCtD
Verteporfin—Asthenia—Dexamethasone—psoriasis	2.96e-05	0.000322	CcSEcCtD
Verteporfin—Asthenia—Betamethasone—psoriasis	2.96e-05	0.000322	CcSEcCtD
Verteporfin—Nervous system disorder—Methotrexate—psoriasis	2.95e-05	0.000321	CcSEcCtD
Verteporfin—Nausea—Prednisolone—psoriasis	2.94e-05	0.00032	CcSEcCtD
Verteporfin—Pruritus—Dexamethasone—psoriasis	2.92e-05	0.000318	CcSEcCtD
Verteporfin—Pruritus—Betamethasone—psoriasis	2.92e-05	0.000318	CcSEcCtD
Verteporfin—Skin disorder—Methotrexate—psoriasis	2.92e-05	0.000318	CcSEcCtD
Verteporfin—Hyperhidrosis—Methotrexate—psoriasis	2.91e-05	0.000316	CcSEcCtD
Verteporfin—Nausea—Hydrocortisone—psoriasis	2.87e-05	0.000312	CcSEcCtD
Verteporfin—Rash—Triamcinolone—psoriasis	2.87e-05	0.000312	CcSEcCtD
Verteporfin—Dermatitis—Triamcinolone—psoriasis	2.87e-05	0.000312	CcSEcCtD
Verteporfin—Urticaria—Prednisone—psoriasis	2.86e-05	0.000311	CcSEcCtD
Verteporfin—Headache—Triamcinolone—psoriasis	2.85e-05	0.00031	CcSEcCtD
Verteporfin—Body temperature increased—Prednisone—psoriasis	2.84e-05	0.000309	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Methotrexate—psoriasis	2.74e-05	0.000298	CcSEcCtD
Verteporfin—Dizziness—Dexamethasone—psoriasis	2.73e-05	0.000297	CcSEcCtD
Verteporfin—Dizziness—Betamethasone—psoriasis	2.73e-05	0.000297	CcSEcCtD
Verteporfin—Nausea—Triamcinolone—psoriasis	2.7e-05	0.000294	CcSEcCtD
Verteporfin—Dyspnoea—Methotrexate—psoriasis	2.68e-05	0.000291	CcSEcCtD
Verteporfin—Hypersensitivity—Prednisone—psoriasis	2.65e-05	0.000288	CcSEcCtD
Verteporfin—Rash—Betamethasone—psoriasis	2.6e-05	0.000283	CcSEcCtD
Verteporfin—Rash—Dexamethasone—psoriasis	2.6e-05	0.000283	CcSEcCtD
Verteporfin—Dermatitis—Dexamethasone—psoriasis	2.6e-05	0.000283	CcSEcCtD
Verteporfin—Dermatitis—Betamethasone—psoriasis	2.6e-05	0.000283	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Methotrexate—psoriasis	2.6e-05	0.000282	CcSEcCtD
Verteporfin—Headache—Dexamethasone—psoriasis	2.59e-05	0.000281	CcSEcCtD
Verteporfin—Headache—Betamethasone—psoriasis	2.59e-05	0.000281	CcSEcCtD
Verteporfin—Asthenia—Prednisone—psoriasis	2.58e-05	0.000281	CcSEcCtD
Verteporfin—Pain—Methotrexate—psoriasis	2.57e-05	0.00028	CcSEcCtD
Verteporfin—Pruritus—Prednisone—psoriasis	2.54e-05	0.000277	CcSEcCtD
Verteporfin—Feeling abnormal—Methotrexate—psoriasis	2.48e-05	0.000269	CcSEcCtD
Verteporfin—Nausea—Dexamethasone—psoriasis	2.45e-05	0.000267	CcSEcCtD
Verteporfin—Nausea—Betamethasone—psoriasis	2.45e-05	0.000267	CcSEcCtD
Verteporfin—Urticaria—Methotrexate—psoriasis	2.39e-05	0.00026	CcSEcCtD
Verteporfin—Dizziness—Prednisone—psoriasis	2.38e-05	0.000259	CcSEcCtD
Verteporfin—Body temperature increased—Methotrexate—psoriasis	2.38e-05	0.000258	CcSEcCtD
Verteporfin—Rash—Prednisone—psoriasis	2.27e-05	0.000247	CcSEcCtD
Verteporfin—Dermatitis—Prednisone—psoriasis	2.27e-05	0.000246	CcSEcCtD
Verteporfin—Headache—Prednisone—psoriasis	2.25e-05	0.000245	CcSEcCtD
Verteporfin—Hypersensitivity—Methotrexate—psoriasis	2.21e-05	0.000241	CcSEcCtD
Verteporfin—Asthenia—Methotrexate—psoriasis	2.16e-05	0.000235	CcSEcCtD
Verteporfin—Nausea—Prednisone—psoriasis	2.14e-05	0.000232	CcSEcCtD
Verteporfin—Pruritus—Methotrexate—psoriasis	2.13e-05	0.000231	CcSEcCtD
Verteporfin—Dizziness—Methotrexate—psoriasis	1.99e-05	0.000216	CcSEcCtD
Verteporfin—Rash—Methotrexate—psoriasis	1.9e-05	0.000206	CcSEcCtD
Verteporfin—Dermatitis—Methotrexate—psoriasis	1.89e-05	0.000206	CcSEcCtD
Verteporfin—Headache—Methotrexate—psoriasis	1.88e-05	0.000205	CcSEcCtD
Verteporfin—Nausea—Methotrexate—psoriasis	1.79e-05	0.000194	CcSEcCtD
